| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 07/03/2013 | EP2610254A1 Deuterated benzoquinoline derivatives as inhibitors of vesicular monoamine transporter 2 |
| 07/03/2013 | EP2609919A2 c-Met modulators and methods of use |
| 07/03/2013 | EP2609091A1 Pharmaceutically active compounds as axl inhibitors |
| 07/03/2013 | EP2609086A1 Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators |
| 07/03/2013 | EP2609085A1 Substituted quinoline-3-carboxamides as kcnq2/3 modulators |
| 07/03/2013 | EP2609084A1 Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators |
| 07/03/2013 | EP2609083A1 Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators |
| 07/03/2013 | EP2609082A1 Imidazo[4,5-c]quinolines as dna-pk inhibitors |
| 07/03/2013 | CN103189383A Biaryl diphosphine ligands, intermediates of the same and their use in asymmetric catalysis |
| 07/03/2013 | CN103189357A Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators |
| 07/03/2013 | CN103189356A N-heteroaryl compounds |
| 07/03/2013 | CN103183637A Quinoline derivatives and use thereof as fungicides |
| 07/03/2013 | CN101678007B Gonadotropin-releasing hormone receptor antagonists and its pharmaceutical application |
| 07/02/2013 | US8476443 Fluorescent dyes |
| 07/02/2013 | US8476442 Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| 07/02/2013 | US8476432 Process for the preparation of HMG-COA reductase inhibitors and intermediates thereof |
| 07/02/2013 | US8476429 Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| 07/02/2013 | US8476298 c-Met modulators and method of use |
| 07/02/2013 | US8476276 Pharmaceutical compositions based on kinin B2 receptor antagonists and corticosteroids, and their use |
| 07/02/2013 | US8476255 Histone deacetylase inhibitors |
| 07/02/2013 | CA2540536C Salts and polymorphs of a potent antidiabetic compound |
| 06/27/2013 | WO2013096771A1 Non-systemic tgr5 agonists |
| 06/27/2013 | WO2013096226A1 Trpv1 antagonists |
| 06/27/2013 | WO2013096223A1 Trpv1 antagonists |
| 06/27/2013 | WO2013096194A1 Novel heterocyclic carboxamides as modulators of kinase activity |
| 06/27/2013 | WO2013095708A1 Novel neuromodulatory compounds |
| 06/27/2013 | WO2013092556A1 Metal-chelating compounds having at least one polyamino chain |
| 06/27/2013 | US20130165479 Antagonists of the trpv1 receptor and uses thereof |
| 06/27/2013 | US20130165458 Quinazoline compounds as kinase inhibitors |
| 06/27/2013 | US20130165442 Modulators of ATP-Binding Cassette Transporters |
| 06/27/2013 | US20130165440 JAK1 Inhibitors |
| 06/27/2013 | US20130161848 Process for making sterile aripiprazole of desired mean particle size |
| 06/27/2013 | CA2856448A1 Novel heterocyclic carboxamides as modulators of kinase activity |
| 06/26/2013 | CN103180298A Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydr o-4-oxoquinoline-3-carboxamide |
| 06/26/2013 | CN103180297A Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 06/26/2013 | CN103180294A Diamine, polyimide precursor, polyimide, liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element |
| 06/26/2013 | CN103172697A Process for preparing macrocyclic compounds |
| 06/26/2013 | CN103172564A Preparation method of aripiprazole |
| 06/26/2013 | CN103172563A Industrialized preparation of small-particle-size crystal-form I aripiprazole |
| 06/25/2013 | US8471030 Purification of montelukast using simulated moving bed |
| 06/25/2013 | US8471029 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 06/25/2013 | US8471027 Adamantyl compounds |
| 06/25/2013 | US8470852 Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators |
| 06/25/2013 | US8470842 Hydrochloride salts of 8-[{1-(3,5-Bis-trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor |
| 06/25/2013 | US8470529 Methine-substituted cyanine dye compounds |
| 06/25/2013 | US8470208 Organometallic complexes |
| 06/25/2013 | CA2627598C Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
| 06/25/2013 | CA2562082C Cetp inhibitors for the treatment and prevention of atherosclerosis |
| 06/25/2013 | CA2285241C Substituted 3-cyano quinolines |
| 06/20/2013 | WO2013090929A1 Amino quinoline derivatives inhibitors of hcv |
| 06/20/2013 | WO2013087932A1 Coupler with 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses |
| 06/20/2013 | WO2013087931A1 Coupler with cationic 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses |
| 06/20/2013 | US20130158067 TRPV1 Antagonists |
| 06/20/2013 | US20130157947 Compounds for stem cell differentiation |
| 06/19/2013 | EP2603492A1 Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof |
| 06/19/2013 | CN103168031A Tetrahydroquinoline derivatives used as AMPK activators |
| 06/19/2013 | CN103159676A Compounds and application thereof |
| 06/19/2013 | CN103159646A Hydroxamic acid compound, and preparation method and application thereof |
| 06/19/2013 | CN102015585B Method for producing unsaturated organic compound |
| 06/19/2013 | CN101180302B Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 06/19/2013 | CN101065359B Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery |
| 06/18/2013 | US8466290 STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 06/18/2013 | US8466157 Proteasome inhibitors having chymotrypsin-like activity |
| 06/13/2013 | WO2013058511A3 Method for preparing high-purity montelukast sodium salt |
| 06/13/2013 | WO2013017715A3 Quinolyl nitrones |
| 06/13/2013 | US20130150392 Iminopropene compound and use thereof |
| 06/13/2013 | US20130150368 Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| 06/13/2013 | US20130150359 Pyrazoloquinolines |
| 06/13/2013 | US20130150358 Theramutein modulators |
| 06/12/2013 | EP2600860A1 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat proteins |
| 06/12/2013 | CN103153959A 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators |
| 06/12/2013 | CN103153958A Novel microbiocidal dioxime ether derivatives |
| 06/12/2013 | CN103153945A 1-hydroxyimino-3-phenyl-propanes |
| 06/12/2013 | CN103145615A Posttreatment method of nemonoxacin chelate |
| 06/12/2013 | CN103145614A Method for preparing 8-hydroxyquinoline magnesium nano sheet by room-temperature solid-state chemical reaction |
| 06/12/2013 | CN103145613A Method for synthesizing (E)-3-[2-cyclopropyl-4-(4-fluorophenyl) quinolinyl-2-propenal |
| 06/12/2013 | CN102153570B Quick synthesis method of reverse-2-(2-hydroxy styryl)-8-oxyquinoline zinc |
| 06/12/2013 | CN101868448B 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 06/12/2013 | CN101790376B Tsh receptor antagonizing tetrahydroquinoline compounds |
| 06/12/2013 | CN101607973B Organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/12/2013 | CN101522631B Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the ss2 adrenergic receptor |
| 06/11/2013 | US8461346 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 06/11/2013 | US8461339 Pharmaceutical compounds |
| 06/11/2013 | US8461182 7-piperidinoalkyl-3, 4-Dihydroquinolone derivative |
| 06/06/2013 | WO2013081783A1 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics |
| 06/06/2013 | WO2013081400A2 Novel benzamide derivative and use thereof |
| 06/06/2013 | WO2013081044A1 Tablet containing 1-cyclopropyl-8-(difluoromethoxy)-7-[(1r)-1-methyl-2, 3-dihydro-1h-isoindole-5-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid methanesulfonic acid hydrate |
| 06/06/2013 | WO2013079708A1 2-(substituted-phenyl)-cyclopentane-1,3-dione compounds, and derivatives thereof |
| 06/06/2013 | US20130144063 Crystalline Pharmaceutical and Methods of Preparation and Use Thereof |
| 06/06/2013 | US20130143917 (2e)-3-phenyl-n-[2,2,2-trifluoro-1-[[8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof |
| 06/06/2013 | US20130142758 Novel hydroxamates as therapeutic agents |
| 06/06/2013 | CA2857236A1 2-(substituted-phenyl)-cyclopentane-1,3-dione compounds, and derivatives thereof |
| 06/06/2013 | CA2855001A1 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics |
| 06/05/2013 | EP2598487A1 Novel microbiocidal dioxime ether derivatives |
| 06/05/2013 | EP2598486A1 Bicyclic acetyl-coa carboxylase inhibitors |
| 06/05/2013 | EP2598485A2 Novel montelukast 4-halobenzylamine salt and method for preparing montelukast sodium salt by using the same |
| 06/05/2013 | EP2598484A1 Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof |
| 06/05/2013 | EP2597955A1 Quinoline derivatives and melk inhibitors containing the same |
| 06/05/2013 | CN103140474A Napht- 2 -ylacetic acid derivatives to treat aids |
| 06/05/2013 | CN103140221A Novel heterocyclic derivatives and pharmaceutical composition containing same |